Download PDF

Other users also viewed these articles

Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure Francisco J. Blanco; Esteban Rubio-Romero; Raimon Sanmartí; César Díaz-Torné; Pablo Talavera; Jochen Dunkel; Esperanza Naredo;
Reumatol Clin. 2020;16P1:345-52
Mean corpuscular volume and red cell distribution width as predictors of methotrexate response in RA patients Benitez Cristian Alejandro; Gomez Ramiro Adrián; Peón Claudia; Alfaro María Agustina; Federico Andrea; Klimovsky Ezequiel; Gamba María Julieta;
Reumatol Clin. 2025;21:
Clinical course and flare predictors in patients with rheumatoid arthritis in low disease activity and ultrasound remission monitored by ultrasound yearly and on-demand: A prospective 2-year observation study Takeo Abe; Masao Tamura; Kazuyuki Tsuboi; Yuko Minagawa; Kazuteru Noguchi; Chie Ogita; Teppei Hashimoto; Naoto Azuma; Kiyoshi Matsui;
Reumatol Clin. 2024;20:517-25